“Designed for Visibility, Engineered for Strength”
CarboFix Spine Launches CarboClear® Hybrid MIS Pedicle Screw System Advancing Minimally Invasive Spine Surgery with Carbon Fiber Hybrid Technology

Richardson, TX — July 20, 2026 — CarboFix Spine, a leader in Carbon Fiber spinal implant innovation, today announced the launch of its CarboClear® Hybrid MIS Pedicle Screw System, expanding the capabilities of its established Hybrid platform into minimally invasive spine (MIS) procedures.
Designed to complement the CarboClear Hybrid Pedicle Screw System, the new MIS solution delivers enhanced surgical efficiency while maintaining the imaging and clinical advantages of carbon fiber-reinforced technology.
The CarboClear Hybrid MIS System is cleared for use in oncology and degenerative indications.
The CarboClear Hybrid MIS system incorporates a carbon fiber-reinforced PEEK (CFRP) screw shank with a titanium tulip, providing the added benefit of imaging—critical for intra- and postoperative imaging, radiation planning, and radiation treatment.
Key Features and Benefits:
Minimally Invasive Design with Break-off Reduction Tabs: Streamlines MIS workflows, enabling controlled reduction and simplified rod insertion
Dual-Lead Thread Technology: Enhances insertion efficiency and improves purchase in varying bone qualities
System Compatibility: Fully compatible with existing CarboClear carbon fiber rods, allowing integration into current surgical workflows without additional instrumentation burden
“The launch of our MIS pedicle screw system represents a natural evolution of the CarboClear Hybrid platform,” said John Miller, US VP Sales & Marketing at CarboFix Spine. “Surgeons can now leverage the benefits of carbon fiber technology in minimally invasive approaches—without sacrificing efficiency, versatility, or compatibility with our existing carbon fiber systems.”
By extending its Hybrid portfolio into MIS applications, CarboFix Spine continues to support surgeons in addressing a wide spectrum of spinal pathologies, including degenerative, trauma, and oncology.
For more information, visit www.carbofixspine.com or contact Sean Reynolds, Director of Marketing USA.
About CarboFix Spine
CarboFix Spine is a pioneering medical device company focused on developing carbon fiber spinal implants that improve imaging clarity and support optimized patient care, particularly in oncology and degenerative applications. The CarboClear® product family is designed to address the limitations of traditional metallic implants while maintaining strength and clinical versatility.
Media Contact:
Sean Reynolds, DBA
Director of Marketing
sean@carbo-fix.com
+1(800) 408-0120
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
CarboFix Spine launched its CarboClear® Hybrid MIS Pedicle Screw System, strategically expanding its carbon fiber-reinforced technology into the growing minimally invasive spine market. This move enhances surgical efficiency and leverages existing platform compatibility, targeting oncology and degenerative indications. The system aims to capture market share by offering superior imaging benefits crucial for radiation planning and treatment, differentiating from traditional metallic implants.
- CarboFix Spine's strategy involves extending its established Hybrid platform into MIS, broadening its market reach and product portfolio.
- The system offers a competitive advantage through carbon fiber's imaging clarity, crucial for oncology, and compatibility with existing CarboClear rods, easing adoption.
PhD Lens: Clinical and outcomes impact
The CarboClear® Hybrid MIS Pedicle Screw System integrates a carbon fiber-reinforced PEEK (CFRP) screw shank with a titanium tulip, designed for enhanced intra- and postoperative imaging clarity, particularly beneficial for radiation planning and treatment in oncology. This hybrid material approach maintains structural strength while improving visibility, addressing limitations of traditional metallic implants in specific clinical contexts.
- The system utilizes a CFRP screw shank for radiolucency and a titanium tulip for strength, optimizing imaging without compromising mechanical integrity.
- Dual-Lead Thread Technology improves insertion efficiency and bone purchase, while break-off reduction tabs streamline MIS workflows.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.